BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...
LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
The Associated Press on MSN5d
Don’t wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccinesHealth officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...
News Medical on MSN5d
Public trust in COVID-19 vaccine science influences vaccine uptake in the USResearchers investigate how public trust in the science of COVID-19 vaccines has changed in the United States.
AstraZeneca is set to report its third-quarter 2024 earnings Tuesday morning. The company's Q2 performance suggests strong ...
A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
AstraZeneca ( (AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca ...
CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the ...
VOV.VN - Báo điện tử VOV, tin tức thời sự về chính trị, kinh tế, đời sống, xã hội, pháp luật, thể thao, văn hóa, giải trí, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback